Clinical Trial

Multiple Myeloma t(4 ;14) FFPE Samples

Study acronym: MM-t4-14-FFPE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This observational study aims to evaluate the feasibility of assembling a retrospective cohort of formalin-fixed paraffin-embedded (FFPE) tissue samples from patients with 4;14 translocated multiple myeloma, together with their associated clinical and pathological data. The study will determine whether these archived samples are suitable for exploratory biomarker assessment. No intervention is performed. All FFPE samples and clinical data originate exclusively from routine diagnostic procedures and will be analyzed retrospectively for research purposes.
Trial Details
NCT Number NCT07482761
Lead Sponsor BIWAKO
Conditions Multiple Myeloma and Malignant Plasma Cell Neoplasms
Enrollment 20 participants
Start Date 2026-07-05
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-19